Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $2.52 billion. The enterprise value is $2.33 billion.
| Market Cap | 2.52B |
| Enterprise Value | 2.33B |
Important Dates
The next confirmed earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 526.68 million shares outstanding. The number of shares has increased by 5.19% in one year.
| Current Share Class | 430.97M |
| Shares Outstanding | 526.68M |
| Shares Change (YoY) | +5.19% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 21.77% |
| Owned by Institutions (%) | 24.27% |
| Float | 408.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 48.04 |
| PS Ratio | 1.13 |
| Forward PS | 0.83 |
| PB Ratio | 6.96 |
| P/TBV Ratio | 7.44 |
| P/FCF Ratio | 45.92 |
| P/OCF Ratio | 43.74 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 42.74 |
Financial Position
The company has a current ratio of 1.33
| Current Ratio | 1.33 |
| Quick Ratio | 1.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.86% and return on invested capital (ROIC) is -10.53%.
| Return on Equity (ROE) | -16.86% |
| Return on Assets (ROA) | -5.55% |
| Return on Invested Capital (ROIC) | -10.53% |
| Return on Capital Employed (ROCE) | -15.76% |
| Weighted Average Cost of Capital (WACC) | 17.57% |
| Revenue Per Employee | $3.05M |
| Profits Per Employee | -$78,648 |
| Employee Count | 724 |
| Asset Turnover | 3.45 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.76% in the last 52 weeks. The beta is 2.42, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | +62.76% |
| 50-Day Moving Average | 4.36 |
| 200-Day Moving Average | 2.91 |
| Relative Strength Index (RSI) | 52.93 |
| Average Volume (20 Days) | 6,358,472 |
Short Selling Information
The latest short interest is 22.18 million, so 4.21% of the outstanding shares have been sold short.
| Short Interest | 22.18M |
| Short Previous Month | 24.85M |
| Short % of Shares Out | 4.21% |
| Short % of Float | 5.43% |
| Short Ratio (days to cover) | 2.44 |
Income Statement
In the last 12 months, CLOV had revenue of $2.21 billion and -$56.94 million in losses. Loss per share was -$0.11.
| Revenue | 2.21B |
| Gross Profit | 405.75M |
| Operating Income | -56.92M |
| Pretax Income | -56.94M |
| Net Income | -56.94M |
| EBITDA | -56.69M |
| EBIT | -56.92M |
| Loss Per Share | -$0.11 |
Balance Sheet
The company has $203.54 million in cash and n/a in debt, with a net cash position of $173.27 million or $0.33 per share.
| Cash & Cash Equivalents | 203.54M |
| Total Debt | n/a |
| Net Cash | 173.27M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 339.43M |
| Book Value Per Share | 0.65 |
| Working Capital | 111.44M |
Cash Flow
In the last 12 months, operating cash flow was $57.25 million and capital expenditures -$2.71 million, giving a free cash flow of $54.54 million.
| Operating Cash Flow | 57.25M |
| Capital Expenditures | -2.71M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 54.54M |
| FCF Per Share | $0.10 |
Margins
Gross margin is 18.36%, with operating and profit margins of -2.58% and -2.58%.
| Gross Margin | 18.36% |
| Operating Margin | -2.58% |
| Pretax Margin | -2.58% |
| Profit Margin | -2.58% |
| EBITDA Margin | -2.56% |
| EBIT Margin | -2.58% |
| FCF Margin | 2.47% |
Dividends & Yields
CLOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.19% |
| Shareholder Yield | -5.19% |
| Earnings Yield | -2.27% |
| FCF Yield | 2.18% |
Analyst Forecast
The average price target for CLOV is $4.58, which is -4.38% lower than the current price. The consensus rating is "Buy".
| Price Target | $4.58 |
| Price Target Difference | -4.38% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 23.98% |
| EPS Growth Forecast (3Y) | 60.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |